Detalhe da pesquisa
1.
Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Nature
; 558(7710): E1, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769713
2.
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Nature
; 550(7674): 128-132, 2017 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28953875
3.
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases.
Bioorg Med Chem Lett
; 39: 127854, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631370
4.
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.
Nat Chem Biol
; 13(3): 317-324, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114273
5.
Hit to Lead optimization of a novel class of squarate-containing polo-like kinases inhibitors.
Bioorg Med Chem Lett
; 22(24): 7615-22, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23103095
6.
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor.
ACS Med Chem Lett
; 12(5): 726-731, 2021 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34055218
7.
IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases.
Sci Rep
; 9(1): 17675, 2019 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776355
8.
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
Clin Cancer Res
; 13(9): 2728-37, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17473206
9.
Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
Mol Cancer Ther
; 17(12): 2543-2550, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266801
10.
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase.
ACS Med Chem Lett
; 6(1): 58-62, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589931